Yuhan shares once hit 200,000 won
Published: 2007-08-08 06:57:00
Updated: 2007-08-08 06:57:00
Shares of Yuhan Corporation, one of the leading pharmaceutical firms in Korea, briefly surpassed 200,000-won level on August 3 thanks to robust sales of Levanex, a homegrown antiulcerant, opening a new chapter for the local pharmaceutical industry, analysts said.
Shares of Yuhan rose 1.58 perc...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
